Sar(1)-Me-Tyr(4)- angiotensin II

angiotensin II antagonist

Also Known As:

angiotensin II, Sar(1)-Me-Tyr(4)-; 1-Sar-4-Me-Tyr-angiotensin II; SMT-angiotensin II; angiotensin II, sarcosyl(1)-methyltyrosine(4)-; sarmesin; Angiotensin II, 1-(N-methylglycine)-4-(O-methyl-L-tyrosine)-5-L-isoleucine-, (3beta)-

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Hypertension (High Blood Pressure) 05/20/1999 - "An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic resonance spectroscopy and theoretical calculations."
2.	Seizures (Absence Seizure) 07/01/1999 - "Pretreatment with saralasin and sarmesin antagonized the Ang II effect on the latency to seizures. " 07/01/1999 - "Sarmesin and saralasin significantly increased the latency to seizures as well as survival time. "
3.	Hypoxia (Hypoxemia) 07/01/1999 - "The effects of angiotensin II (Ang II) and angiotensin receptor ligands sarmesin ([Sar1, Tyr(Me)4] Ang II) and saralasin ([Sar1, Ala8] Ang II) administered intracerebroventricularly (i.c.v.) on acute anoxic hypoxia were studied in mice. "

Related Drugs and Biologics

1.	Losartan (Cozaar)
2.	Saralasin (Saralasin Acetate)
3.	Angiotensin Receptors (Angiotensin II Receptor)
4.	Ligands
5.	Angiotensin II